PET/CT in Thyroid Cancer
This pocket book provides a comprehensive review of the current use of PET/CT in thyroid cancer, offering a multidisciplinary perspective and explaining the role of PET/CT in relation to other imaging modalities. A key aim is to help readers to choose the
- PDF / 4,546,850 Bytes
- 93 Pages / 439.42 x 666.14 pts Page_size
- 13 Downloads / 195 Views
han Vinjamuri Editor
PET/CT in Thyroid Cancer
Clinicians’ Guides to Radionuclide Hybrid Imaging PET/CT Series Editors Jamshed B. Bomanji London, UK Gopinath Gnanasegaran London, UK Stefano Fanti Bologna, Italy Homer A. Macapinlac Houston, Texas, USA
More information about this series at http://www.springernature.com/series/13803
Sobhan Vinjamuri Editor
PET/CT in Thyroid Cancer
Editor Sobhan Vinjamuri Department of Nuclear Medicine Royal Liverpool and Broadgreen University Hospitals NHS Trust Liverpool UK
ISSN 2367-2439 ISSN 2367-2447 (electronic) Clinicians’ Guides to Radionuclide Hybrid Imaging - PET/CT ISBN 978-3-319-71845-3 ISBN 978-3-319-71846-0 (eBook) https://doi.org/10.1007/978-3-319-71846-0 Library of Congress Control Number: 2018930909 © Springer International Publishing AG, part of Springer Nature 2018 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by the registered company Springer International Publishing AG part of Springer Nature The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
PET/CT series is dedicated to Prof Ignac Fogelman, Dr Muriel Buxton-Thomas and Prof Ajit K Padhy
Foreword
Clear and concise clinical indications for PET/CT in the management of oncology patient are presented in this series of 15 separate booklets. Early and accurate diagnosis, better staging, tailored management and specific treatment of cancer in patients have been achieved with the advent of this multimodality imaging technology. Clear information on treatment responses can be collected using PET/CT, as well as prognostic information, which can serve as a guide for additional therapeutic options. PET/CT was fortunately able to derive a great benefit from radionuclide-labelled probes, which deliver often excellent target and non-target signals. Whilst labelled gl
Data Loading...
